Unnecessary pathology tests performed in intensive care units (ICU) might lead to increased costs of care and potential patient harm due to unnecessary phlebotomy. We hypothesised that a multimodal intervention program could result in a safe and effective reduction in the pathology tests ordered in our ICU. We conducted a single-centre pre-and post-study using multimodal interventions to address commonly ordered routine tests. The study was performed during the same six month period (August to February) over three years: 2012 to 2013 (pre-intervention), 2013 to 2014 (intervention) and 2014 to 2015 (post-intervention). Interventions consisted of staff education, designing new pathology forms, consultant-led pathology test ordering and intensive monitoring for a six-month period. The results of the study showed that there was a net savings of over A$213,000 in the intervention period and A$175,000 in the post-intervention period compared to the pre-intervention period. There was a 28% reduction in the tests performed in the intervention period (P <0.0001 compared to pre-intervention period) and 26% in the post-intervention period (P <0.0001 compared to pre-intervention period). There were no ICU or hospital mortality differences between the groups. There were no significant haemoglobin differences between the groups. A multimodal intervention safely reduced pathology test ordering in the ICU, resulting in substantial cost savings.
1
. At more than four times the cost of regular hospital care, and accounting for 28% of all acute care charges, ICU treatment comes at a substantial opportunity cost to the rest of the healthcare system 2 . Cost-saving initiatives would have widespread benefit. ICU costs are multifactorial and mostly non-discretionary, but pathology tests account for at least five percent of the total cost of care 3 . Patients in ICU often undergo a large panel of daily routine diagnostic tests with no indication other than surveillance for occult complications. The benefit of this practice has never been established. Between 30% 4 and two-thirds 5 of laboratory testing in hospital is likely wasteful. The high frequency of testing introduces greater risk of false-positive test results 6 . Unnecessary testing also leads to unnecessary blood loss through phlebotomy, causing clinically significant anaemia and transfusion requirement. Corwin et al reported that the blood loss could be 40 to 70 ml/day and up to one litre per ICU stay 7 . Conservative phlebotomy in ICU limits blood loss 8 . Transfusion and associated complications are well known and add to the burden of healthcare expenditure. Additionally, there may be other costs of transfusion such as infection risk, nursing workload and patient discomfort. Thus, to the public health system the financial burden of daily unnecessary laboratory testing is substantial.
Modifying test-ordering practices in ICU is challenging. The multidisciplinary and dynamic ICU work environment makes it difficult to identify which tests are unnecessary for a particular patient on a particular day 9 . Strategies to address unnecessary laboratory test ordering [9] [10] [11] [12] [13] have mostly focused on standing orders prohibiting routine biochemistry and haematology blood tests [9] [10] [11] . However, currently there are no universally applicable guidelines for laboratory test ordering in ICU.
We hypothesised that implementing a multimodal strategy including education, modification of the laboratory test ordering form, senior medical staff-guided ordering, and implementation of a change management strategy that involved monitoring and feedback would result in safe and cost-effective outcomes, and that these benefits would persist over time. We tested this hypothesis in a before-andafter study in our multidisciplinary ICU.
Materials and methods

Ethics approval
The study was approved by the hospital ethics committee (EC00172), approval number HREC/13/QRBW/284.
Study design
This was a non-randomised pre-and post-intervention study.
Study setting and patients
The study was conducted in the ICU of the Royal Brisbane and Women's Hospital. This is a 22-bed tertiary academic ICU operating a 'closed' model of care in which intensivists take primary responsibility for all aspects of patient care. While there are seasonal variations, the case-mix is approximately 50% medical and 50% surgical, with all specialties referring except cardiac surgery. A consultant intensivist is continuously present to lead 'on-the-floor' patient management during the daytime. Overnight, a senior registrar is present with a consultant intensivist on call. Junior medical officers (JMOs) with varying experience, and from a variety of subspecialties, manage routine care including physical ordering of laboratory investigations. The six-month ICU terms for JMOs commence in February and August.
Pre-intervention
Pre-intervention, the overnight JMOs initiated laboratory ordering in a self-directed manner. Overnight ordering and testing avoided contributing to the substantial laboratory workload during the daytime, and facilitated availability of results during consultant rounds. The section for writing orders on the laboratory order forms was blank, allowing any test to be ordered, with no formal guidelines available.
To avoid any potential confounding effect of seasonal variations in patient population and JMO rotations, we conducted the study in the same six-month period (7 August to 6 February) across three years. The study periods were the pre-intervention period, 2012 to 2013-consisting of preexisting practices; the intervention period, 2013 to 2014-when interventions were performed as per the details given below; and the post-intervention period, 2014 to 2015-in which intensive monitoring was absent, to observe the longer-term sustainability of the intervention.
Interventions
During the intervention period, we introduced practice alterations with explicit participation by the medical staff. These included prescribing guidelines and new tools such as a new laboratory form.
1) Review and targeting tests: After reviewing existing literature and conducting an internal audit of the tests commonly performed, the coagulation screen and biochemistry panel were identified as the tests to be targeted for patient-specific indications alone.
2) Redesigning the laboratory order form: The previous order form was redesigned to include clear tick boxes to facilitate limited test ordering. Boxes listed full blood count (FBC), urea/electrolytes/creatinine (UEC), full biochemistry panel including renal and liver function tests and calcium, magnesium, phosphate (Chem 20), full coagulation panel, International Normalized Ratio (INR), activated partial thromboplastin time (APTT), and fibrinogen. These were the most common laboratory tests performed during the preintervention period, similar to previous reports 14 . The form also provided guidelines for specific test indications ( Figure  1 ). The combination of tick boxes and guidelines with order sets was deemed to be complementary and facilitated the ordering process.
3) Medical staff education: Several educational goals were identified and addressed. There was poor understanding of the costs of the various test panels. Patients transferred to our ICU from other units and other hospitals routinely had tests that had already been performed earlier the same day needlessly repeated. Many tests were repeated more frequently than daily. We used forums such as routine weekly administrative staff meetings, scheduled education sessions, email and posters. At the beginning of the intervention period, a comprehensive orientation program was conducted where Fellows and JMOs were educated about the project.
4) Consultant intensivist-led ordering practices: We had the entire intensivist group participate actively in the study. During the intervention period, the intensivists planned the next day's laboratory test ordering during their afternoon ward rounds. The completed order forms were placed in a designated folder and handed over to the night JMO. The tests were performed in the early morning hours (between 0400 and 0600 hours) and the results made available for the morning handover (between 0700 and 0800 hours). The ICU senior registrar could add tests if indicated by an evolving clinical situation. 5) Intensive monitoring: At least one investigator or research assistant was present at the beginning of the afternoon ward round to facilitate the process by providing the laboratory forms. The investigator and the research assistant used this opportunity for education around the purpose of the intervention as well as the processes involved. Another visit in the evening was made to ensure that the laboratory forms were completed and kept in the designated place. The tests ordered were at the discretion of the treating intensivist and no attempts were made to interfere or influence this practice.
Data collection
We collected demographic characteristics and clinical and laboratory parameters by retrospective audit of the electronic patient record. Clinical parameters consisted of diagnosis, Acute Physiology and Chronic Health Evaluation (APACHE) III severity of illness score, length of stay (LOS) in ICU, and ICU and hospital outcome. Laboratory data included the number and type of tests ordered, and the number of tests with results outside the laboratory reference range. We also collected data on the use of invasive organ-support measures such as duration of mechanical ventilation and dialysis, along with the number of packed red blood cell transfusions for the ICU admission. The costs of individual tests were obtained from Pathology Queensland, Queensland Health, Australia.
Statistical analyses
Numbers of tests, costs, and outcomes of ICU patients in the two follow-up periods, intervention and postintervention, were compared with the pre-intervention period.
The study was non-randomised and is therefore vulnerable to the potential confounding effect of differences in patient characteristics and intercurrent care amongst the three time periods. We assessed the likelihood of this confounding by comparing baseline patient characteristics including age, gender, source of admission (medical/surgical) and APACHE III score using Student's t-tests or chi-square tests as appropriate. No correction was made for multiple testing 15 . We used plots to compare the three time periods together with tables of summary statistics. We estimated changes between the three time periods using multiple regression analysis with a dependent variable of the key outcome (e.g. LOS) and independent variables of time period and the potential confounders of APACHE III score, age, gender, ICU admission source, dialysis and ventilation.
To understand the association between the study period and outcome (ICU and hospital mortality), logistic regression models were built using all available predictor variables (APACHE III score, age, surgical/non-surgical category, duration of mechanical ventilation or continuous renal replacement therapy (CRRT), chronic respiratory failure, liver failure, and immunosuppression). More parsimonious models (in which the study period remained forced into the model) did not improve model fit, and so only the full models are reported.
Results that spanned the patient's stay (e.g. administration of blood products) were standardised by their LOS and the results are presented on a scale of per patient per day. All analyses were made in R version 3.3.0 16 .
Results
Demographic characteristics
There were 1,141 patients in the pre-intervention period, 1,067 in the intervention period and 1,042 in the postintervention period (Table 1 ). Data for all the patients was available for analyses. The patient groups were comparable in their age and gender. The APACHE III score was statistically significantly higher in the intervention group than the preintervention group; the difference in APACHE III between the pre-and post-intervention groups did not reach statistical significance. There was a significantly lower mean bed occupancy during the post-intervention period, so more beds were available in this period compared to the preintervention period. The lower number of occupied bed days could lead to fewer tests ordered, however we adjusted for this by standardisation to per patient per day.
Primary aims
There was a statistically significant reduction of A$28.26 (95% confidence interval (CI) A$31.64 to A$24.88) per patient per day in the cost of pathology tests during the intervention period. This decreased in the post-intervention period to a saving of A$24.45 (95% CI A$27.86 to A$21.04) per patient per day. There was an overall net saving of A$213,326 in the intervention period and A$175,267 in the post-intervention period, compared to the pre-intervention period.
In the intervention period, there was a significant reduction in FBC (12%), Chem 20 (44%), and coagulation panel tests increased. In the post-intervention period, differences in the test ordering persisted. Overall there were 28% fewer tests performed in the intervention period and 26% fewer in the post-intervention period. To test the effect of longer ICU stay, the data was analysed with and without including day one of the admission as more tests are likely to be performed on day one. This showed that the differences in the INR and APTT were not as pronounced with day one excluded, but remained significantly less. Other differences were maintained.
Compared to the pre-intervention group, there was a 17.9% reduction in the packed red blood cell usage in the intervention group, but this apparent reduction did not reach statistical significance (P=0.26). Similarly, apparent reductions in fresh frozen plasma and platelet transfusions in the intervention and post-intervention periods were not statistically significant (Table 3) .
Secondary aims
The percentages of abnormal test results are shown in Table 4 , with fewer abnormal tests results in the intervention and the post-intervention period. This is despite the increased severity of illness in patients during the intervention period, as reflected in the APACHE III scores. The differences in abnormal tests results between the groups was small. Table 5 shows patient outcome data using multiple regression models adjusted for APACHE III score, age, gender, and ICU admission source. Median LOS in ICU had clinically and statistically insignificant differences (median difference within 0.3 days) between study periods. Mortality was comparable between the study periods. There was no difference in the number of patients mechanically ventilated or the duration of mechanical ventilation between the pre-intervention and intervention periods, but there was a significant reduction (compared to the pre-intervention period) in the duration of mechanical ventilation and number of patients ventilated in the post-intervention period. Requirement for, and duration of, CRRT was similar in the three study periods. Multivariable regression analysis of potential predictors of ICU and hospital mortality with all the study periods (Tables 6a and 6b) showed that the study period was not associated with mortality. When comparing the admission-to-discharge haemoglobin difference, the groups were comparable (Table 7) .
Discussion
Our interventions were associated with a significant reduction in the number of blood tests ordered. The apparent reduction in blood product transfusion rates was not statistically significant. The study groups were comparable with the important exception that the APACHE III score was higher in the intervention group than in the pre-intervention group. This difference only accentuates the effect of our intervention, as the benefits persisted despite the greater severity of illness in this group. The reduced blood product usage in this period would have resulted in additional cost savings, both direct and indirect. Predictably, as the coagulation panel tests decreased significantly, the number of individual coagulation tests increased in the intervention and the post-intervention group. Being a tertiary referral hospital, patients may have had tests done elsewhere prior to transfer. Hence, as per the guidelines, they may have had individual tests done at the time of ICU admission instead of the full coagulation screen, potentially explaining the differences seen in Table 2a and 2b. The significantly decreased proportion of abnormal test results in the intervention group compared to the preintervention group was despite the increased severity of illness. Thus, contrary to conventional wisdom, higher severity of illness need not correlate to more laboratory tests.
Most of the benefits persisted in the post-intervention group, showing the longer-term sustainability of the intervention.
An intervention that results in fewer diagnostic tests might plausibly be associated with overall patient harm. Although there was no evidence of harm in the outcomes we studied, it is possible that other adverse effects were not observed. Moreover, the crude retrospectively analysed data in the study might not detect subtle harm. Whilst there is a focus on reducing tests, a 15-year meta-analysis of the use of laboratory tests found both over-and under-use is widespread 4 . It is therefore deemed important to incorporate the principle of the 'right test in the right patient at the right time'. In our study, the mortality rate, ICU LOS, duration of mechanical ventilation, and dialysis duration was comparable between groups.
Seasonal variations in the pathology and demography of critically ill patients have been reported in literature 17 . Similar variations are also observed in our ICU. We conducted our study of sustained intensive interventions over a six-month period. The study periods were chosen to commence the same number of weeks after the change of JMO's terms, so that the familiarity of the medical officers with the ICU practice would not be a confounding factor in the relationship between study period and the measured outcomes.
Medical reversal 18 -the phenomenon of abandoning current practice-takes a long time 19 , longer than introducing a new practice 20 . One study reported the large variations in the physician-attributable costs in ICU 21 . Whilst we did not study this variable, it emphasises the importance of a uniform buy-in by all intensivists, as was the case in our study. Ordering patterns are also shown to correlate with duration of clinical exposure, with those taught to rely on clinical examination and judgement early in training likely to order less laboratory tests 22 . Thus, by setting an example by direct demonstration of appropriate test ordering, the trainees may learn the right habits thus ensuring future compliance. It has also been shown that the menu of choices for test ordering has a direct impact on the ordering patterns 23 . By designing the pathology order forms to limit choice as in our study, it may be possible to reduce test ordering. For data analysis, it is seen that adjusting for severity of illness scores enables comparison of data between units 24 . Hence, we have adjusted the important outcome data to APACHE III scores.
Several other investigators have studied different strategies to reduce the pathology cost of critical care 9, 11, [25] [26] [27] [28] . Rachakonda et al reported a significant reduction of tests ordered by instituting consultant-led high-volume test ordering 26 . We adopted this strategy in our study. Musca et al introduced a clinical guideline and an education program to successfully reduce coagulation tests and associated laboratory costs in a tertiary ICU 29 . Our study included coagulation tests along with other high-volume, frequently performed tests, as well as quantifying some measures of the safety of the interventions. Read et al substituted a daily routine testing practice by on-demand testing which led to a substantial reduction in the number of tests ordered and cost savings 27 . Due to an already significant daytime workload in our laboratories and hence potential delayed results, we did not apply this practice in our study. Applying a 24-hour limit for repetition of the test led to reduction in the tests in a paediatric intensive care setting in one study 11 . The study did not report on the safety outcomes of the interventions. In our setting, it was deemed by the intensivists that patient diagnoses might necessitate repetition of the tests, hence we did not implement this intervention. Introducing a laboratory test order chart filled in for tests to be performed the following day led to a reduction in the tests and the associated costs in the study by Goddard and Austin 30 . We mimicked this intervention in our study. Guidelines for the ordering of routine laboratory tests and chest X-rays resulted in reduction of tests and costs in Prat et al's study 28 . In one study, incorporating guidelines and the routine practice of discussing laboratory tests on ward rounds led to fewer tests 9 . Our study included guidelines as one of the interventions, although this was limited to pathology tests only. Having a list of acceptable indications for tests such as complete blood count, renal function tests and electrolytes and incorporating ordering in the afternoon ward rounds led to reduction in the tests and cost savings in the study by Iosfina et al 10 . We did not prescribe indications for the tests and instead relied on continuous education as a strategy. Interestingly, providing information about the costs of individual tests resulted in less test ordering by the clinicians in Seguin et al's study 25 . The consultant intensivists in our ICU felt that while this intervention may reduce test ordering, it could be a disincentive to performing otherwise appropriate tests thus resulting in patient harm.
Thus, although the results are variable, it is apparent from the studies that a variety of interventions could result in cost savings. Many factors contribute to test ordering and most test-reducing interventional studies have been performed in different settings as well as using different endpoints, rendering meta-analysis for cost-reducing interventions inappropriate or impossible. Although the majority of ICU expenditure is non-discretionary 3 , abnormal results from a screening test performed without a clinical indication could potentially lead to further testing and treatments that are not indicated. Hence, cost implications may still be important.
Limitations
We studied only the pre-specified tests that we knew were commonly ordered in our ICU. It is possible that other tests might have been substituted for those we targeted, which could have offset the savings we observed. However, the comprehensive list of tests we studied makes this unlikely.
Our study did not include point-of-care tests such as arterial blood gases and viscoelastic coagulation tests, which have specific indications and should be studied separately. Although the reduction in our coagulation tests could possibly lead to increase in the ordering of viscoelastic coagulation tests, our ICU at the time of the study did not have this technology. There might have been other unaccounted-for interventions or events that could have influenced the results, including awareness and education from other departments. Although the study realised cost savings for the ICU, there could be other costs to the pathology services that may affect the overall cost to the health service.
The study sought to evaluate only a period of six months in the year. Whilst it is possible that the results could be different in the rest of year, this is unlikely; the periods studied covered summer and winter months to the same degree. We have studied the effects of the intervention for a period of one-year post-implementation. It is not certain if the effects would last over a longer period and a followup study at the five-year and ten-year intervals will be important. We used a pragmatic pre-post design and whilst we controlled for known confounders there may have been other changes that we were unaware of.
Conclusion
Our study shows that successful implementation of a multimodal strategy consisting of a consultant-led ordering practice, education and a menu-based ordering aimed at rationalisation of commonly ordered pathology tests was associated with significant cost savings. There was no associated increase in patient morbidity or mortality. The benefits of the interventions were sustained one year after the intervention period. 
